by PierianDx, on June 16, 2021
Comprehensive Genetic Profiling Supplements Germline and Companion Diagnostic Results to Provide Holistic View for Oncologists and Patients
Read Storyby PierianDx, on December 1, 2020
Additional Illumina assays to be combined with the PierianDx platform to reduce time, cost, and complexity of genomic reporting
Read Storyby PierianDx, on November 18, 2020
Mark McDonough named as Chief Executive Officer (CEO) and member of the Board of Directors of PierianDx
Read Storyby PierianDx, on October 14, 2020
Multiple targeted assays from Pillar Biosciences to be combined with the PierianDx platform to reduce time, cost, and complexity of clinical genomic testing
Read Storyby PierianDx, on May 5, 2020
Collaboration will create integrated clinical interpretation and reporting solution
Read Storyby PierianDx, on December 11, 2019
Intermountain Healthcare joins PierianDx’s partner network to accelerate precision medicine
Read Storyby PierianDx, on October 28, 2019
Funding led by ATW Partners and SJF Ventures with follow-on Investment from Health Catalyst Capital, RTI International, and Inova Health Systems
Read Storyby PierianDx, on January 4, 2019
Comprehensive pan-cancer tumor profiling assays to be combined with clinical informatics platform with the potential to reduce time, cost, and complexity of clinical genomic analysis
Read Storyby Josh Forsythe, on June 11, 2018
PierianDx, the leading clinical genomics technology company that enables precision medicine, announced today that the Department of Anatomical Pathology PathWest Laboratory Medicine will use the company’s Clinical Genomics WorkSpace™ (CGW) platform, the industry’s leading integrated workspace for clinical genomic analytics, classification, interpretation and reporting.
Read Storyby Josh Forsythe, on June 1, 2018
by Josh Forsythe, on May 23, 2018
MAY 24, 2018 -- ST. LOUIS -- PierianDx, the leader in clinical genomics solutions, announced today that it has appointed Michael L. Sanderson as Chief Executive Officer and Director of the Board. In his new role, Sanderson will execute on the company’s strategy to integrate PierianDx’s unique value proposition for molecular labs into the broader precision medicine and healthcare delivery markets.
Read Storyby Josh Forsythe, on May 13, 2018
MAY 14, 2018 -- ST. LOUIS -- PierianDx, the leading clinical genomics technology company that enables precision medicine, announced today that it has executed a distribution agreement with ScienceVision, a leading provider of end-to-end genomic solutions in the Asia Pacific region.
Read Story
Global phone number: (314) 628-0035
U.S. Office: 6 Cityplace Dr Suite 550, Creve Coeur, MO 63141
India Office: 2/A, Chattushringi, Gokhalenagar, Pune, Maharashtra 411016, India
